ArticleJournal of hematology & oncology2021

A novel CD123-targeted therapeutic peptide loaded by micellar delivery system combats refractory acute myeloid leukemia.

Shilin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.